Cardiol Therapeutics Inc.(CRDL)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.1M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
CRDL Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Cardiol Therapeutics Inc. (CRDL), a Healthcare sector company. CRDL is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.1m in revenue. Top institutional holders of CRDL by reported 13-F value include MMCAP International SPC, Tejara Capital Ltd, Ikarian Capital,, based on the most recent SEC filings. CRDL trades on the Nasdaq exchange and files with the SEC under CIK 1702123. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CRDL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cardiol Therapeutics Inc. directly from SEC EDGAR.
Get alerted when CRDL's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Cardiol Therapeutics Inc. including:
Top Institutional Holders of CRDL
MMCAP International Inc. SPC
$20.7M15,352,317 shTejara Capital Ltd
$6.9M5,130,122 shIkarian Capital, LLC
$3.7M2,725,000 shCITADEL ADVISORS LLC
$1.1M819,904 shBOOTHBAY FUND MANAGEMENT, LLC
$1.1M794,881 shTWO SIGMA INVESTMENTS, LP
$721.2K534,211 shINTEGRITY ALLIANCE, LLC.
$629.8K465,025 shGOLDMAN SACHS GROUP INC
$448.7K332,400 shMORGAN STANLEY
$338.1K250,421 shRENAISSANCE TECHNOLOGIES LLC
$310.2K229,806 sh
| Fund | Value | Shares |
|---|---|---|
| MMCAP International Inc. SPC | $20.7M | 15,352,317 |
| Tejara Capital Ltd | $6.9M | 5,130,122 |
| Ikarian Capital, LLC | $3.7M | 2,725,000 |
| CITADEL ADVISORS LLC | $1.1M | 819,904 |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.1M | 794,881 |
| TWO SIGMA INVESTMENTS, LP | $721.2K | 534,211 |
| INTEGRITY ALLIANCE, LLC. | $629.8K | 465,025 |
| GOLDMAN SACHS GROUP INC | $448.7K | 332,400 |
| MORGAN STANLEY | $338.1K | 250,421 |
| RENAISSANCE TECHNOLOGIES LLC | $310.2K | 229,806 |
More Healthcare Companies
View all Healthcare →Put CRDL on your watchlist
Track score changes the day Cardiol Therapeutics Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CRDL a good stock to buy?
13F Pro's AI-powered analysis of Cardiol Therapeutics Inc. (CRDL) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CRDL are available on the CRDL stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own CRDL?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CRDL. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Cardiol Therapeutics Inc.'s investment landscape.